pfNL43-dE-EGFP 质粒 (编号: V000058)
基本信息
pfNL43-dE-EGFP can be employed to construct HIV pseudoviruses, enabling visualisation of the infection process through EGFP labelling. This facilitates the detection of compounds' anti-HIV activity and assists in evaluating therapeutic efficacy.
- 载体名称
- pfNL43-dE-EGFP
- 载体抗性
- Ampicillin
- 载体长度
- 12872 bp
- 载体类型
- Mammalian Expression, Lentiviral, Retroviral
- 复制子
- ori
- 拷贝数
- High Copy
- 感受态
- Stbl3
质粒操作方法
质粒复溶方法
- 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
- 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
- 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
- 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
- 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
- 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
- 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。
通用质粒转化方法
- 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
- 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
- 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
- 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
- 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。
参考文献
- Ratanabunyong S, Seetaha S, Hannongbua S, Yanaka S, Yagi-Utsumi M, Kato K, Paemanee A, Choowongkomon K. Biophysical Characterization of Novel DNA Aptamers against K103N/Y181C Double Mutant HIV-1 Reverse Transcriptase. Molecules. 2022 Jan 3;27(1):285. doi: 10.3390/molecules27010285. PMID: 35011517; PMCID: PMC8746315.
pfNL43-dE-EGFP 质粒 (编号: V000058) 注释
LOCUS Exported 12872 bp DNA circular SYN 03-NOV-2025
DEFINITION Exported.
ACCESSION V000058
VERSION .
KEYWORDS pfNL43-dE-EGFP
SOURCE synthetic DNA construct
ORGANISM synthetic DNA construct
REFERENCE 1 (bases 1 to 12872)
TITLE NLdDIS
JOURNAL Unpublished
REFERENCE 2 (bases 1 to 12872)
TITLE Direct Submission
REFERENCE 3 (bases 1 to 12872)
TITLE Direct Submission
REFERENCE 4 (bases 1 to 12872)
AUTHORS .
TITLE Direct Submission
COMMENT SGRef: number: 1; type: "Journal Article"; journalName:
"Unpublished"
COMMENT SGRef: number: 2; type: "Journal Article"
COMMENT SGRef: number: 3; type: "Journal Article"
FEATURES Location/Qualifiers
source 1..12872
/mol_type="other DNA"
/organism="synthetic DNA construct"
LTR 69..326
/label=5' LTR (truncated)
/note="truncated 5' long terminal repeat (LTR) from HIV-1"
misc_feature 373..498
/label=HIV-1 Psi
/note="packaging signal of human immunodeficiency virus
type 1"
CDS 482..1984
/codon_start=1
/gene="gag"
/product="gag protein from human immunodeficiency virus 1"
/label=HIV-1 gag
/translation="MGARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFA
VNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYNTIAVLYCVHQRIDVKDTKEALDKI
EEEQNKSKKKAQQAAADTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKA
FSPEVIPMFSALSEGATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGP
IAPGQMREPRGSDIAGTTSTLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTS
ILDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPG
ATLEEMMTACQGVGGPGHKARVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEG
HIAKNCRAPRKKGCWKCGKEGHQMKDCTERQANFLGKIWPSHKGRPGNFLQSRPEPTAP
PEESFRFGEETTTPSQKQEPIDKELYPLASLRSLFGSDPSSQ"
CDS 1777..4788
/codon_start=1
/gene="pol"
/product="pol protein from human immunodeficiency virus 1"
/label=HIV-1 pol
/translation="FFREDLAFPQGKAREFSSEQTRANSPTRRELQVWGRDNNSLSEAG
ADRQGTVSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIG
GIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETV
PVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKD
STKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRK
YTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMD
DLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPI
VLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELEL
AENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHT
NDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPP
LVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQ
AIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAH
KGIGGNEQVDKLVSAGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVA
SCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQET
AYFLLKLAGRWPVKTVHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVIESMNK
ELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQK
QITKIQNFRVYYRDSRDPVWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQ
MAGDDCVASRQDED"
misc_feature 4473..4590
/label=cPPT/CTS
/note="central polypurine tract and central termination
sequence of HIV-1"
CDS 4733..5308
/gene="vif"
/label=Virion infectivity factor
/note="Virion infectivity factor from Human
immunodeficiency virus type 1 group M subtype B (isolate
NY5). Accession#: P12504"
CDS 5522..5695
/label=Protein Tat
/note="Protein Tat from Human immunodeficiency virus type 1
group M subtype B (isolate BH5). Accession#: P04612"
CDS 5753..5995
/gene="vpu"
/label=Protein Vpu
/note="Protein Vpu from Human immunodeficiency virus type 1
group M subtype B (isolate BH10). Accession#: P69699"
regulatory 6045..6054
/label=Kozak sequence
/note="vertebrate consensus sequence for strong initiation
of translation (Kozak, 1987)"
/regulatory_class="other"
CDS 6051..6767
/label=EGFP
/note="enhanced GFP"
misc_feature 7289..7522
/label=RRE
/note="The Rev response element (RRE) of HIV-1 allows for
Rev-dependent mRNA export from the nucleus to the
cytoplasm."
CDS 7707..7751
/label=gp41 peptide
/note="antigenic peptide corresponding to amino acids 655
to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
al., 2013)"
CDS 8045..8071
/label=NES
/note="nuclear export signal from the HIV Rev protein
(Fischer et al., 1995)"
CDS 8317..8343
/gene="nef"
/label=Protein Nef
/note="Protein Nef from Human immunodeficiency virus type 1
group M subtype D (isolate Z84). Accession#: P12481"
LTR 8606..9239
/label=3' LTR
/note="3' long terminal repeat (LTR) from HIV-1"
primer_bind complement(10235..10252)
/label=L4440
/note="L4440 vector, forward primer"
rep_origin complement(10406..10994)
/direction=LEFT
/label=ori
/note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
replication"
CDS complement(11165..12025)
/codon_start=1
/gene="bla"
/product="beta-lactamase"
/label=AmpR
/note="confers resistance to ampicillin, carbenicillin, and
related antibiotics"
/translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
EPELNEAIPNDERDTTKPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
LIKHW"
promoter complement(12026..12130)
/label=AmpR promoter
primer_bind 12198..12216
/label=pBRforEco
/note="pBR322 vectors, upsteam of EcoRI site, forward
primer"
primer_bind complement(12254..12276)
/label=pGEX 3'
/note="pGEX vectors, reverse primer"
primer_bind 12376..12395
/label=pRS-marker
/note="pRS vectors, use to sequence yeast selectable
marker"